References
- Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50-51):1378–1382.
- Gummin DD, Mowry JB, Spyker DA, et al. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018;56(12):1213–1415.
- Hedegaard H, Warner M, Minino AM. Drug overdose deaths in the United States, 1999-2015. NCHS Data Brief. 2017;(273):1–8.
- Ford JA. Misuse of over-the-counter cough or cold medications among adolescents: prevalence and correlates in a national sample. J Adolesc Health. 2009;44(5):505–507.
- Karami S, Major JM, Calderon S, et al. Trends in dextromethorphan cough and cold products: 2000-2015 National Poison Data System intentional abuse exposure calls. Clin Toxicol (Phila)). 2018;56(7):656–663.
- Wilson MD, Ferguson RW, Mazer ME, et al. Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000-2010. Clin Toxicol (Phila). 2011;49(5):409–415.
- Sheridan DC, Hendrickson RG, Lin AL, et al. Adolescent suicidal ingestion: national trends over a decade. J Adolesc Health. 2017;60(2):191–195.
- Benotsch EG, Koester S, Martin AM, et al. Intentional misuse of over-the-counter medications, mental health, and polysubstance use in young adults. J Commun Health. 2014;39(4):688–695.
- Vakkalanka JP, Charlton NP, Holstege CP. Epidemiologic trends in loperamide abuse and misuse. Ann Emerg Med. 2017;69(1):73–78.
- Lasoff DR, Koh CH, Corbett B, et al. Loperamide trends in abuse and misuse over 13 years: 2002-2015. Pharmacotherapy. 2017;37(2):249–253.
- Gosselin S. Antihistamines and decongestants. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. editors. Goldfrank’s toxicologic emergencies, 11e. New York, NY: McGraw-Hill; 2019.
- Rowe C, Verjee Z, Koren G. Adolescent dimenhydrinate abuse: resurgence of an old problem. J Adolesc Health. 1997;21(1):47–49.
- Conca AJ, Worthen DR. Nonprescription drug abuse. J Pharm Pract. 2012;25(1):13–21.
- U.S. Food and Drug Administration; FDA Drug Safety Communication. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-problems-high-doses-allergy-medicine-diphenhydramine-benadryl. Accessed October 5, 2020.
- Glickman L. Diphenhydramine abuse and withdrawal. JAMA. 1986;256(14):1894
- Erbe S, Bschor T. Diphenhydramine addiction and detoxification. A systematic review and case report. Psychiatr Prax. 2013;40(5):248–251.
- Cox D, Ahmed Z, McBride AJ. Diphenhydramine dependence. Addiction. 2001;96(3):516–517.
- American Association of Poison Control Centers. National Poison Data System NPDS Coding Users’ Manual, Version 3.1. 2014.
- U.S. Census Bureau; American Community Survey (ACS), American Fact Finder. https://data.census.gov/cedsci/. Accessed September 15, 2020.
- Insel BJ, Gould MS. Impact of modeling on adolescent suicidal behavior. Psychiatr Clin North Am. 2008;31(2):293–316.
- CDC. National Violent Death Reporting System (NVDRS). Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Injury Prevention and Control; 2018. https://wisqars.cdc.gov:8443/nvdrs/nvdrsDisplay.jsp. [Accessed May 12, 2019].
- Spiller HA, Ackerman JP, Spiller NE, et al. Sex- and age-specific increases in suicide attempts by self-poisoning in the United States among youth and young adults from 2000 to 2018. J Pediatr. 2019;210:201–208.
- U.S. Food & Drug Administration. Sleep Disorder (Sedative-Hypnotic) Drug Information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/sleep-disorder-sedative-hypnotic-drug-information. [Accessed May 10, 2019].
- Abraham O, Schleiden L, Albert SM. Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep. Int J Clin Pharm. 2017;39(4):808–817.
- Sansgiry SS, Bhansali AH, Bapat SS, et al. Abuse of over-the-counter medicines: a pharmacist's perspective. Integr Pharm Res Pract. 2017;6(6):1–6.
- Turvill JL, Burroughs AK, Moore KP. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet. 2000;355(9220):2048–2049.
- Hawton K, Simkin S, Deeks J, et al. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ. 2004;329(7474):1076.
- Hawton K, Bergen H, Simkin S, et al. Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: Interrupted time series analyses. BMJ. 2013;346:f403
- Nonnemaker J, Engelen M, Shive D. Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic? Health Econ. 2011;20(5):519–531.